Phase I Study of HRS-3005 in B-cell Malignancies
Phase I Study of HRS-3005 in B-cell Malignancies
Recruiting · NCT07556822 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of HRS-3005 in B-cell Malignancies | B-cell Malignancy | Recruiting | Phase 1 | 2026-09-09 | NCT07556822 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 132 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hematology Hospital of the Chinese Academy of Medical Sciences | Tianjin | China | 4 |